跳至主要内容
临床试验/NCT02504801
NCT02504801Unknown4 期

Efficacy of Nebulized Pulmicort Respules on Post Operation Pulmonary Complication During Pulmonary Single Lobectomy Surgery in Primary Lung Cancer Patients With COPD

Xiuyi Zhi0 个研究点目标入组 73 人开始时间: 2015年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
73
主要终点
The incidence of post-operation pulmonary complication in two arms among primary lung cancer patients with COPD

研究概览

简要总结

To test the hypothesis that nebulized Pulmicort Respules could reduce post operation pulmonary complication incidence in primary lung cancer patients with COPD. Compare post-operation pulmonary complication incidence in two treatment arms among primary lung cancer patients with COPD required single lobectomy from 3days before operation to 7 days after operation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
40 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Newly diagnosed or existing COPD defined by GOLD, and FEV1 of<80% predicted and FEV1/FVC<70%
  • Diagnosed as primary lung cancer by China guidelines on diagnosis and treatment of primary lung cancer
  • .Consistent with indication of operation of pulmonary single lobectomy surgery by China guidelines on diagnosis and treatment of primary lung cancer
  • General anesthesia and double cavity intubation was used during operation
  • ASA Classification of Anesthesia Risk is in category 1-3 both in baseline
  • age from 40-80 years old
  • Smoking cessation more than two weeks before operation
  • SP O2>90% before surgery
  • Hemoglobin > 10g/dl
  • Estimated duration of surgery < 4 hours
  • 18.5<BMI < 28

排除标准

  • Patients who had taken systemic corticosteroids in the preceding 1month before baseline
  • Patients who had pneumonia in the preceding 1month before baseline
  • Patients with a history of recent myocardial infarction, heart failure, tuberculosis
  • Subject with known or suspected human immunodeficiency virus infection

研究组 & 干预措施

nebulized Budesonide 2mg/4mL

Active Comparator

+terbutaline 5mg/2mL,BID+ipratropium 2 puff(40ug)BID

干预措施: Budesonide (Drug)

结局指标

主要结局

The incidence of post-operation pulmonary complication in two arms among primary lung cancer patients with COPD

时间窗: 10 days

Definition of post-operation pulmonary complication: 1. Pneumonia/other pulmonary infections, with X-ray evidence, fever and/or WBC\>15,000mL 2. Sputum retention:classified as purulent and the pour ability grade is 1 or 2 3. Acute respiratory failture or chronic respiratory failture 4. Atelectasis 5. Aerothorax:\>30% by X-ray; pulmonary embolism

次要结局

未报告次要终点

研究者

发起方
Xiuyi Zhi
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Xiuyi Zhi

Professor

Xuanwu Hospital, Beijing

相似试验